Dear Editor:
The economic impact the COVID-19 pandemic has in Peru is very significant. This will be reflected in the health context our country is going through. As a consequence, the budget allocation becomes a serious responsibility for the various activities that health facilities (EESS, by its acronyms in Spanish) need for timely, safe and quality care
(1,2).
Considering that the quality of health services is patient-oriented with a process approach, but especially decision-making based on facts. Each of these components will be reduced by the pandemic
(3). Considering that the health objectives expected to be achieved require supplies, which are necessary since they allow us to develop activities ( processes), deliver products, and thus, achieve the health results we expect. In the context in which we live, two actors play a very important role. From the budgetary perspective, the State basically allocates two budgets: 11 Ministry of Health (MINSA, by its acronyms in Spanish) and 134 budget, National Superintendency of Health (SUSALUD, by its acronyms in Spanish). MINSA ensures medical supplies are available, while SUSALUD ensures the continuity and compliance of medical processes in EESS.
At the beginning of 2020, the MINSA had been assigned S/. 1 761 million to be allocated for the expenditure on critical supplies required by EESS. In the case of SUSALUD, S/ 21 million was allocated to ensure activities related to the promotion and protection of health rights, supervision of Institutions Managing Health Insurance Funds and Institutions Health Services and regulation, authorization, registration and control. However, with the COVID-19 pandemic, these budgets increased considerably. In the case of MINSA the budget for COVID-19, in the middle of the year, reached S/. 1 532 million and no additional resources were allocated for SUSALUD (
Table 1).
Table 1. Budget allocation and execution of the Ministry of Health (MINSA) and National Superintendency of Health (SUSALUD) in the context of the COVID-19 pandemic, Peru, 2020
Supplies/activities
|
No COVID-19
|
COVID-19
|
Budget (S/.)
|
BE(%)
|
Budget (S/.)
|
BE(%)
|
MINSA
|
Human resources (SMC)
|
1 198 710 387
|
56,0
|
649 640 866
|
52,7
|
Medicine
|
304 764 353
|
36,8
|
351 476 150
|
34,3
|
Medical materials
|
183 541 923
|
48,8
|
340 075 597
|
55,3
|
Biomedical equipment
|
74 901 951
|
9,9
|
191 228 054
|
13,6
|
Total
|
1 761 918 614
|
|
1 532 420 667
|
|
SUSALUD
|
|
|
|
|
Promotion and protection of health rights
|
9 155 772
|
61,0
|
-
|
-
|
Supervision of IMHIF
|
7 675 320
|
61,6
|
-
|
-
|
Regulation, authorization, registration and control
|
4 259 627
|
60,3
|
-
|
-
|
Total
|
21 090 719
|
-
|
-
|
-
|
SMC: Service Management Contract (D. S. 1057) IMHIF: Institutions Managing Health Insurance Funds BE: Budget Execution to August 2020
Source: MEF consultation. Reported on 08/28/2020 (https://apps5.mineco.gob.pe/transparencia/Navegador/default.aspx)
Own production
However, these resources contrast significantly with budget execution.
Table 1 clearly shows the low budget execution in critical non-COVID-19 budget supplies, especially in biomedical equipment. While for COVID-19, it shows an execution of 13,6% and even so, it is very low. Therefore, the supplies needed will not be timely provided and as a result, the processes will be very limited, even more so with the zero budget allocation to SUSALUD.
If we want to ensure quality care in our EESS, it is necessary to have these supplies. There is much to be done from now on in terms of improving the quality of health services
(4). First, in relation to human resources. It is necessary to have timely and spaced hiring. It is impractical to renew these processes monthly; in these circumstances it should be, at least, between 6 to 12 months. Second, materials and medical supplies, medicines and vaccines. To do this, the preparation of the technical files must be insured in advance with the development of standards that reduce the bureaucratic processes of acquisition of these resources, focusing on the areas where the greatest delays are produced. Even anticipating the beginning of the fiscal year, acquiring critical supplies as much as for drugs as for medical devices must be prioritized. Third, in relation to equipment and infrastructure. Having an equipment Plan, as well as having the record of equipment that count in the Integrated Administrative Management System (SIGA, by its acronyms in Spanish) module property. No less important, infrastructure. Although it is not shown in the analysis, it is important to develop investment projects.
In times of pandemic, it is a priority to take these aspects into account. We will still continue to live with this problem; we are aware that it is not only a health problem, but a multisectoral one. But from the perspective of the health sector, there is much to do: trained decision makers, for example. There is a body of public managers to serve technical teams (healthcare and administrative staff called logistics, planners, administrators, among others) with clear objectives and complemented with the participation of civil society. If this is not done, the economic impact will be very significant.
(5,6)
Our contribution also aims to point out the need to carry out budgetary impact studies of the supplies to be acquired, complemented by process evaluations, as well as economic studies (cost-effectiveness, cost-utility). This will allow timely use of these supplies, but especially, to develop quality care.
Authorship contributions: The authors participated in the genesis of the idea, data collection, writing and final version of the original article.
Funding sources: This article was self-funded by the authors.
Conflicts of interest: The authors declare they have no conflicts of interest regarding this article.
Recibido: 03 de setiembre de 2020
Aprobado: 09 de diciembre de 2020
Correspondence: Alfonso Gutierrez Aguado
Address: Av. Petit Thouars 2021, Lince 15046.
Telephone: +51 988 493 448
Email: alfonso2805@gmail.com
REFERENCES
1. Ashraf BN. Economic impact of government interventions during the COVID-19 pandemic: International evidence from financial markets. J Behav Exp Finance. 2020 Sep;27:100371. doi: 10.1016/j.jbef.2020.100371.
2. Vázquez-Rowe I, Gandolfi A. Peruvian efforts to contain COVID-19 fail to protect vulnerable population groups. Public Health in Practice. 2020 Nov;1:100020. doi: 10.1016/j.puhip.2020.100020. Epub 2020 Jun 11. PMCID: PMC7286823.
3. Schwendicke F, Krois J, Gomez J. Impact of SARS-CoV2 (Covid-19) on dental practices: Economic analysis. J Dent. 2020 Aug;99:103387. doi: 10.1016/j.jdent.2020.103387. Epub 2020 May 27. PMID: 32473182; PMCID: PMC7255191.
5. Chou YC, Yen YF, Feng RC, et al. Impact of the COVID-19 Pandemic on the Utilization of Hospice Care Services: A Cohort Study in Taiwan [published online ahead of print, 2020 Jul 11]. J Pain Symptom Manage. 2020;S0885-3924(20)30591-1. doi:10.1016/j.jpainsymman.2020.07.005
6. Ma X, Vervoort D, Reddy CL, Park KB, Makasa E. Emergency and essential surgical healthcare services during COVID-19 in low- and middle-income countries: A perspective. Int J Surg. 2020 Jul;79:43-46. doi: 10.1016/j.ijsu.2020.05.037. Epub 2020 May 16.